These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 29964204

  • 1. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
    Xiao Y, Li Y, Tao H, Humphries B, Li A, Jiang Y, Yang C, Luo R, Wang Z.
    Cancer Lett; 2018 Oct 01; 433():199-209. PubMed ID: 29964204
    [Abstract] [Full Text] [Related]

  • 2. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
    Li Y, Xiao Y, Lin HP, Reichel D, Bae Y, Lee EY, Jiang Y, Huang X, Yang C, Wang Z.
    Biomaterials; 2019 Jan 01; 188():160-172. PubMed ID: 30352320
    [Abstract] [Full Text] [Related]

  • 3. SNHG3 silencing suppresses the malignant development of triple-negative breast cancer cells by regulating miRNA-326/integrin α5 axis and inactivating Vav2/Rac1 signaling pathway.
    Wang P, Liu GZ, Wang JF, Du YY.
    Eur Rev Med Pharmacol Sci; 2020 May 01; 24(10):5481-5492. PubMed ID: 32495883
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis.
    Humphries B, Wang Z, Oom AL, Fisher T, Tan D, Cui Y, Jiang Y, Yang C.
    Carcinogenesis; 2014 Oct 01; 35(10):2254-63. PubMed ID: 24925028
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL, Zhang ZJ, Yi ZB, Li JJ.
    Br J Cancer; 2017 Jun 27; 117(1):78-88. PubMed ID: 28571042
    [Abstract] [Full Text] [Related]

  • 6. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC, Wang JX, Han ML, Zhang LP, Li L.
    Cell Oncol (Dordr); 2017 Apr 27; 40(2):157-166. PubMed ID: 28054302
    [Abstract] [Full Text] [Related]

  • 7. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N.
    Oncotarget; 2017 Jan 10; 8(2):3072-3103. PubMed ID: 27902969
    [Abstract] [Full Text] [Related]

  • 8. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis.
    Wang J, Li M, Han X, Wang H, Wang X, Ma G, Xia T, Wang S.
    Cell Death Dis; 2020 Jul 03; 11(7):500. PubMed ID: 32620748
    [Abstract] [Full Text] [Related]

  • 9. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S, Zhou J, Wang Z, Wang P, Gao X, Wang Y.
    Biomed Pharmacother; 2018 Aug 03; 104():451-457. PubMed ID: 29793177
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer.
    Yan M, Li X, Tong D, Han C, Zhao R, He Y, Jin X.
    Oncol Rep; 2016 Jul 03; 36(1):65-71. PubMed ID: 27108696
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Integrin α9 depletion promotes β-catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis.
    Wang Z, Li Y, Xiao Y, Lin HP, Yang P, Humphries B, Gao T, Yang C.
    Int J Cancer; 2019 Nov 15; 145(10):2767-2780. PubMed ID: 31008533
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
    Zhou W, Song F, Wu Q, Liu R, Wang L, Liu C, Peng Y, Mao S, Feng J, Chen C.
    PLoS One; 2017 Nov 15; 12(4):e0176395. PubMed ID: 28437471
    [Abstract] [Full Text] [Related]

  • 16. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F, Luo N, Hu Y, Li X, Zhang K.
    Cell Physiol Biochem; 2018 Nov 15; 47(5):2147-2158. PubMed ID: 29975921
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
    Lv ZD, Yang DX, Liu XP, Jin LY, Wang XG, Yang ZC, Liu D, Zhao JJ, Kong B, Li FN, Wang HB.
    Cell Physiol Biochem; 2017 Nov 15; 44(5):1785-1795. PubMed ID: 29216628
    [Abstract] [Full Text] [Related]

  • 19. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H, Sang M, Liu F, Ai N, Geng C.
    Pathol Res Pract; 2019 Apr 15; 215(4):697-704. PubMed ID: 30611621
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
    Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N, Aslan B, Oguztuzun S, Ulasli M, Arslan A, Calin G, Lopez-Berestein G, Ozpolat B.
    Oncotarget; 2017 Feb 14; 8(7):11641-11658. PubMed ID: 28036267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.